Literature DB >> 6883323

Comparison of energy metabolism in human normal and neoplastic (Burkitt's lymphoma) lymphoid cells.

S Sariban-Sohraby, I T Magrath, R S Balaban.   

Abstract

In order to detect possible differences in the energy metabolism between normal and neoplastic lymphoid cells, we studied purified normal human lymphocytes (FL) and transformed lymphoblastoid cell lines derived from umbilical cord blood (CL) and compared them to cell lines derived from American Burkitt's lymphoma (BL). The total adenosine triphosphate production rate by these cells was estimated by measuring O2 consumption and lactic acid production rates. O2 consumption (nmol/min/mg protein) was 4.9 +/- 0.3 (S.D.) in CL, 4.4 +/- 0.3 in FL, and 4.9 +/- 0.3 in BL. Lactic acid production (nmol/min/mg protein) was 30.9 +/- 3.0 in CL, 29.9 +/- 3.0 in FL, and 23.4 +/- 4.0 in BL. Using these values of O2 consumption and lactic acid production, the average adenosine triphosphate production rates (nmol/min/mg protein) were calculated to be 60 in CL, 56 in FL, and 53 in BL. We conclude that the BL do not have more aerobic glycolysis than do normal lymphoid cells, suggesting that the lactic acidosis seen in American Burkitt's lymphoma is not due to a preferential glycolytic metabolism of the tumor. More likely, the lactic acidosis is simply due to the large total mass of these neoplastic cells and not due to a modification of their energy metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883323

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.

Authors:  Erin Gatza; Daniel R Wahl; Anthony W Opipari; Thomas B Sundberg; Pavan Reddy; Chen Liu; Gary D Glick; James L M Ferrara
Journal:  Sci Transl Med       Date:  2011-01-26       Impact factor: 17.956

2.  [How long will preserved blood and bone marrow films give reliable cytochemical staining?].

Authors:  C Herren; U Bucher
Journal:  Klin Wochenschr       Date:  1985-10-15

3.  IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1.

Authors:  Thomas G Sommermann; Kathleen O'Neill; David R Plas; Ellen Cahir-McFarland
Journal:  Cancer Res       Date:  2011-10-10       Impact factor: 12.701

4.  Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha.

Authors:  J Durig; W Fiedler; M de Wit; M Steffen; D K Hossfeld
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

Review 5.  Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.

Authors:  Daniel R Wahl; Craig A Byersdorfer; James L M Ferrara; Anthony W Opipari; Gary D Glick
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 6.  A pivotal role for p53: balancing aerobic respiration and glycolysis.

Authors:  Wenzhe Ma; Ho Joong Sung; Joon Y Park; Satoaki Matoba; Paul M Hwang
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

7.  Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells.

Authors:  Shan He; Koji Kato; Jiu Jiang; Daniel R Wahl; Shin Mineishi; Erin M Fisher; Donna M Murasko; Gary D Glick; Yi Zhang
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

Review 8.  The role of Fatty Acid oxidation in the metabolic reprograming of activated t-cells.

Authors:  Craig Alan Byersdorfer
Journal:  Front Immunol       Date:  2014-12-18       Impact factor: 7.561

9.  Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.

Authors:  Su Yeon Lee; Hyun Min Jeon; Min Kyung Ju; Eui Kyong Jeong; Cho Hee Kim; Hye Gyeong Park; Song Iy Han; Ho Sung Kang
Journal:  Oncotarget       Date:  2016-02-16

10.  The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.

Authors:  Georg Gdynia; Sven W Sauer; Jürgen Kopitz; Dominik Fuchs; Katarina Duglova; Thorsten Ruppert; Matthias Miller; Jens Pahl; Adelheid Cerwenka; Markus Enders; Heimo Mairbäurl; Marcin M Kamiński; Roland Penzel; Christine Zhang; Jonathan C Fuller; Rebecca C Wade; Axel Benner; Jenny Chang-Claude; Hermann Brenner; Michael Hoffmeister; Hanswalter Zentgraf; Peter Schirmacher; Wilfried Roth
Journal:  Nat Commun       Date:  2016-03-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.